Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate Donor Umbilical Cord Blood Transplantation
NCT01652014Phase 2Withdrawn
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Jan 2014
- Primary completion
- Jan 2017
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord blood in hematologic malignancy, sponsored by University of Medicine and Dentistry of New Jersey. Planned start Jan 2014; status: withdrawn.
02
Drugs
umbilical cord blood
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT01652014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01652014.